Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Other Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Dr Reddys Laboratories (RDY) Shares Outstanding (2018 - 2025)

Dr Reddys Laboratories has reported Shares Outstanding over the past 8 years, most recently at $9.6 million for Q1 2025.

  • For Q1 2025, Shares Outstanding rose 379.72% year-over-year to $9.6 million; the TTM value through Mar 2025 reached $9.6 million, up 379.72%, while the annual FY2025 figure was $9.9 million, 389.93% up from the prior year.
  • Shares Outstanding for Q1 2025 was $9.6 million at Dr Reddys Laboratories, up from $2.0 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $9.6 million in Q1 2025 and troughed at $2.0 million in Q1 2024.
  • A 5-year average of $3.6 million and a median of $2.2 million in 2022 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: dropped 8.47% in 2023 and later skyrocketed 379.72% in 2025.
  • Year by year, Shares Outstanding stood at $2.3 million in 2021, then decreased by 2.96% to $2.2 million in 2022, then decreased by 8.47% to $2.0 million in 2023, then fell by 0.84% to $2.0 million in 2024, then surged by 379.72% to $9.6 million in 2025.
  • Business Quant data shows Shares Outstanding for RDY at $9.6 million in Q1 2025, $2.0 million in Q1 2024, and $2.0 million in Q1 2023.